Trials / Completed
CompletedNCT04964011
Board Game Intervention to Improve Cognitive and Daily Functioning
Board Game Intervention to Improve Cognitive and Daily Functioning in Elderly People With Mild Cognitive Impairment: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Yang Shang-Yu · Academic / Other
- Sex
- All
- Age
- 65 Years – 88 Years
- Healthy volunteers
- Accepted
Summary
Background: With the rapid rise of the aging population, the number of seniors with mild cognitive impairment (MCI) has increased, and without timely interventions, participants are at high risk of developing dementia. Board games have become a popular tool for cognitive training, but many board games may not be appropriate for seniors and lack the support of empirical research. Objectives: To examine the effectiveness of a 12-week board game intervention for MCI seniors in improving cognitive functioning and scores on the instrumental activities of daily living (IADL) scale. Methods: A single-blind randomized controlled trial was conducted to collect data from a long-term care facility in central Taiwan. Sixty-eight MCI seniors were recruited and randomized into a board game group (trial group) and a health promotion group (control group). Participants in both groups received a 2-hour intervention once a week for 12 weeks, with the trial group receiving 12 weeks of board games and the control group receiving 12 weeks of health promotion activities. Before and after the intervention, the primary assessment was conducted using the Saint Louis University Mental Status Exam, Contextual Memory Test, and Trail Making Test part-A; the secondary assessment was conducted using the IADL scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Board game intervention | In this study, the two groups, the Board game group (12-week board game intervention) and Health promotion group (12-week general health promotion intervention). |
Timeline
- Start date
- 2020-01-03
- Primary completion
- 2020-01-22
- Completion
- 2020-06-30
- First posted
- 2021-07-15
- Last updated
- 2021-07-15
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04964011. Inclusion in this directory is not an endorsement.